Neoleukin Therapeutics, Inc.
SEC Filing List
NLTX CIK: 0001404644
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| 4 | Statement of changes in beneficial owner... | Mcminn Rachel | Neurogene Inc. | 10/02/2026 | |
| SCHEDULE 13G | ADVISER COMPLIANCE ASSOCIATES LLC /fa | 08/14/2026 | |||
| SCHEDULE 13G/A | Toppan Merrill/FA | 08/14/2026 | |||
| SCHEDULE 13G/A | M2 COMPLIANCE LLC /fa | 08/14/2026 | |||
| 10-Q | Quarterly report pursuant to Section 13 ... | Neurogene Inc. | 08/11/2026 | ||
| 8-K | Current report filing | Neurogene Inc. | 08/11/2026 | ||
| 4 | Statement of changes in beneficial owner... | Cvijic Christine Mikail | Neurogene Inc. | 07/07/2026 | |
| 8-K | Current report filing | Neurogene Inc. | 07/02/2026 | ||
| 424B5 | Prospectus filed pursuant to Rule 424(b)(5) | Neurogene Inc. | Workiva Inc. Wdesk FA01 /fa | 07/02/2026 | |
| 4 | Statement of changes in beneficial owner... | Cvijic Christine Mikail | Neurogene Inc. | 07/02/2026 | |
| No record found. | |||||
| Load More | |||||
